Left atrial appendage occlusion in an older population cohort

Michael Killian1, James O'Regan2, Ruth Torre3

  • 1Bon Secours Hospital, College Road, Cork, Ireland. 111344501@umail.ucc.ie.

Insights

Left atrial appendage occlusion shows promise for stroke prevention in patients with atrial fibrillation who cannot use blood thinners. Initial results indicate high success but lower rates in older, high-risk individuals.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Atrial fibrillation (AF) is a common arrhythmia and a significant stroke risk factor.
  • Direct oral anticoagulants (DOACs) are recommended for AF patients but bleeding risk limits use.
  • Left atrial appendage occlusion (LAAO) offers an alternative for high-bleeding-risk patients.

Purpose of the Study:

  • To evaluate the initial safety and success of LAAO in a single center.
  • To assess LAAO outcomes in an elderly patient cohort with high bleeding risk.

Main Methods:

  • Retrospective analysis of 20 patients undergoing LAAO.
  • Assessment of technical and procedural success rates.
  • Documentation of complications, particularly cardiac tamponade.

Main Results:

  • The study included 20 elderly patients (average age 81), 70% male.
  • 90% had a history of major bleeding, contraindicating anticoagulation.
  • Technical success was 95%, procedural success was 80%. Cardiac tamponade occurred in 10%.

Conclusions:

  • This study reports lower technical and procedural success rates for LAAO compared to historical data.
  • Outcomes were observed in an older population with higher stroke and bleeding risk scores.
  • LAAO demonstrates feasibility but requires careful consideration in high-risk AF patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
16
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
30
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
20
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
22
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
28
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15